EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;33:946-947. doi:10.1016/j.ejcts.2008.01.035
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Neuhauser, B.
PubMed
Right arrow Articles by Neuhauser, B.
Related Collections
Right arrow Great vessels


Letters to the Editor

Reply to Mastroroberto et al.

Serious complications following endovascular thoracic aortic stent-graft repair for type B dissection

Beate Neuhauser*

Department of Vascular Surgery, University Hospital Innsbruck, Austria

Received 22 January 2008; accepted 24 January 2008.

* Corresponding author. Address: Department of Vascular Surgery, University Hospital Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. Tel.: +43 512 504 80800; fax: +43 512 504 22559. (Email: Beate.Neuhauser@i-med.ac.at).

Key Words: Endovascular thoracic aortic repair • Severe complication • Type B dissection

The first 20% of the full text of this article appears below.

We would like to thank Mastroroberto et al. for their comments [1] on our paper regarding our observations in our report called serious complications following endovascular thoracic aortic stent-graft repair for type B dissection [2].

Indication for endovascular repair at our department is a complicated course of type B dissection including thoracic aortic rupture, suspicion of impending rupture, visceral and/or peripheral ischemia, uncontrollable hypertension, and severe therapy-resistant pain as mentioned in our paper within the method part. Medical therapy using vasodilators and beta-blockers is preferred in patients with an uncomplicated course. Conversely to Winnerkvist . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.